Literature DB >> 6381536

Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and a patient with afibrinogenemia.

R A Clark, C R Horsburgh, A A Hoffman, H F Dvorak, M W Mosesson, R B Colvin.   

Abstract

During development of delayed hypersensitivity (DH) skin reactions, fibronectin accumulates in two distinct sites: (a) the dermal interstitium in a pattern similar to fibrin and with a time course similar to that of fibrin deposition and mononuclear cell infiltration, and (b) blood vessel walls in a pattern suggestive of basement membrane staining and with a time course similar to that of endothelial cell proliferation. In vitro fibronectin can bind to monocytes or endothelial cells and simultaneously bind to fibrin or collagen matrices; by such interaction in vivo it may affect cell migration or proliferation. Thus, fibronectin deposition in DH reactions may facilitate cell-matrix interactions; however, the possibility exists that extravascular fibronectin accumulation may be only secondary to interstitial fibrin clot formation, and that blood vessel-associated fibronectin may be only a function of adsorption onto basement membrane (type IV) collagen. To address these possibilities, we investigated the association of fibronectin with fibrin, type IV collagen, and mononuclear cell infiltrates in DH reactions. Skin sites of DH reactions in normal volunteers were biopsied at 24, 48, and 72 h after intradermal challenge and examined by immunofluorescence technique. At all time points most of the interstitial fibronectin coincided with fibrin; however, some interstitial fibronectin was coincident with mononuclear cells positive for HLA-DR or monocyte-specific antigen. The coincidence of fibronectin with mononuclear cells was more apparent in a 48-h DH reaction from a patient with congenital afibrinogenemia. Vessel wall fibronectin was increased by 48 h after challenge and appeared as a fine linear band on the luminal side of a much thicker band of type IV collagen. Thus, the coincidence of extravascular fibronectin with mononuclear cells, its appearance without fibrin in the site from a patient with afibrinogenemia, and incomplete correspondence of vessel wall fibronectin with type IV collagen suggest that fibronectin localization in DH reactions involves endothelial cell and mononuclear cell binding as well as adsorption to fibrin and/or type IV collagen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381536      PMCID: PMC425260          DOI: 10.1172/JCI111468

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

2.  The phenotype of dendritic cells and macrophages.

Authors:  W C Van Voorhis; M D Witmer; R M Steinman
Journal:  Fed Proc       Date:  1983-11

3.  Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation.

Authors:  R A Clark; H F Dvorak; R B Colvin
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

4.  Synthesis of fibronectin, laminin, and several collagens by a liver-derived epithelial line.

Authors:  J M Foidart; J J Berman; L Paglia; S Rennard; S Abe; A Perantoni; G R Martin
Journal:  Lab Invest       Date:  1980-05       Impact factor: 5.662

5.  Chemotaxis of aortic endothelial cells in response to fibronectin.

Authors:  J C Bowersox; N Sorgente
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

6.  Fibronectin-collagen binding and requirement during cellular adhesion.

Authors:  L I Gold; E Pearlstein
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

7.  Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration.

Authors:  R B Colvin; M W Mosesson; H F Dvorak
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

8.  Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes.

Authors:  D A Norris; R A Clark; L M Swigart; J C Huff; W L Weston; S E Howell
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

9.  Fibronectin is produced by blood vessels in response to injury.

Authors:  R A Clark; J H Quinn; H J Winn; J M Lanigan; P Dellepella; R B Colvin
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man.

Authors:  R B Colvin; R A Johnson; M C Mihm; H F Dvorak
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  5 in total

1.  Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation.

Authors:  D E Doherty; P M Henson; R A Clark
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung.

Authors:  J H Peters; M H Ginsberg; B P Bohl; L A Sklar; C G Cochrane
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

3.  A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo.

Authors:  V B Weg; T J Williams; R R Lobb; S Nourshargh
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

Review 4.  T Cell Interstitial Migration: Motility Cues from the Inflamed Tissue for Micro- and Macro-Positioning.

Authors:  Alison Gaylo; Dillon C Schrock; Ninoshka R J Fernandes; Deborah J Fowell
Journal:  Front Immunol       Date:  2016-10-14       Impact factor: 7.561

5.  Inflammation-induced interstitial migration of effector CD4⁺ T cells is dependent on integrin αV.

Authors:  Michael G Overstreet; Alison Gaylo; Bastian R Angermann; Angela Hughson; Young-Min Hyun; Kris Lambert; Mridu Acharya; Alison C Billroth-Maclurg; Alexander F Rosenberg; David J Topham; Hideo Yagita; Minsoo Kim; Adam Lacy-Hulbert; Martin Meier-Schellersheim; Deborah J Fowell
Journal:  Nat Immunol       Date:  2013-08-11       Impact factor: 25.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.